ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 662,30
-0,58%
Dow Jones
39 112,16
-0,76%
DAX
18 177,62
-0,90%
Brent Oil
84,415
0,27%
Bitcoin
62 012,87
0,34%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Nyxoah SA (NYXH)

  7. Nyxoah SA (NYXH) Actualités

NYXH

Nyxoah (NYXH)

Nyxoah SA
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NYXH
DateHeureSourceTitreSymboleSociété
03/06/202422h30GlobeNewswire Inc.Nyxoah to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:NYXHNyxoah SA
03/06/202422h24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
03/06/202422h15GlobeNewswire Inc.Information on the total number of voting rights and sharesNASDAQ:NYXHNyxoah SA
03/06/202422h05GlobeNewswire Inc.Publication relating to transparency notificationsNASDAQ:NYXHNyxoah SA
31/05/202408h00GlobeNewswire Inc.Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional SharesNASDAQ:NYXHNyxoah SA
30/05/202423h20Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NYXHNyxoah SA
28/05/202422h30GlobeNewswire Inc.Information on the Total Number of Voting Rights and SharesNASDAQ:NYXHNyxoah SA
24/05/202422h40Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NYXHNyxoah SA
23/05/202415h59GlobeNewswire Inc.Nyxoah Announces Pricing of OfferingNASDAQ:NYXHNyxoah SA
22/05/202422h10GlobeNewswire Inc.Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering ProgramNASDAQ:NYXHNyxoah SA
22/05/202422h05GlobeNewswire Inc.Nyxoah Announces Proposed Offering of Ordinary SharesNASDAQ:NYXHNyxoah SA
14/05/202422h05GlobeNewswire Inc.Nyxoah Reports First Quarter 2024 Financial and Operating ResultsNASDAQ:NYXHNyxoah SA
13/05/202422h30GlobeNewswire Inc.Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024NASDAQ:NYXHNyxoah SA
10/05/202407h00GlobeNewswire Inc.Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024NASDAQ:NYXHNyxoah SA
11/04/202422h30GlobeNewswire Inc.Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical OfficerNASDAQ:NYXHNyxoah SA
25/03/202407h05GlobeNewswire Inc.Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery FoundationNASDAQ:NYXHNyxoah SA
19/03/202421h05GlobeNewswire Inc.Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary EndpointsNASDAQ:NYXHNyxoah SA
05/03/202422h05GlobeNewswire Inc.Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating ResultsNASDAQ:NYXHNyxoah SA
29/02/202422h30GlobeNewswire Inc.Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceNASDAQ:NYXHNyxoah SA
15/02/202422h30GlobeNewswire Inc.Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024NASDAQ:NYXHNyxoah SA
14/02/202422h17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NYXHNyxoah SA
17/01/202422h05GlobeNewswire Inc.Nyxoah Announces 2024 Strategic PrioritiesNASDAQ:NYXHNyxoah SA
09/01/202422h05GlobeNewswire Inc.Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023NASDAQ:NYXHNyxoah SA
11/12/202307h30GlobeNewswire Inc.Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®NASDAQ:NYXHNyxoah SA
08/12/202322h30GlobeNewswire Inc.Publication Relating to a Transparency NotificationNASDAQ:NYXHNyxoah SA
28/11/202322h30GlobeNewswire Inc.Nyxoah Strengthens its Executive Leadership TeamNASDAQ:NYXHNyxoah SA
21/11/202322h30GlobeNewswire Inc.Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:NYXHNyxoah SA
08/11/202322h05GlobeNewswire Inc.Nyxoah Reports Third Quarter 2023 Financial and Operating ResultsNASDAQ:NYXHNyxoah SA
07/11/202322h30GlobeNewswire Inc.Nyxoah to Participate in the Jefferies London Healthcare ConferenceNASDAQ:NYXHNyxoah SA
26/10/202322h30GlobeNewswire Inc.Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023NASDAQ:NYXHNyxoah SA
 Showing the most relevant articles for your search:NASDAQ:NYXH

Dernières Valeurs Consultées

EU
EN
Bouygues
NASDAQ
GOOGL
Alphabet
EU
PX1
CAC 40
SPI
SP500
S&P 500
EU
VK
Vallourec
EU
PX4
SBF 120
EU
AI
Air Liquide
EU
BEL20
Bel 20
NYSE
MRK
Merck
FTSE
UKX
FTSE 100
EU
MC
Lvmh Moet Hennessy Louis...
EU
CAP
Capgemini
EU
DG
Vinci
COIN
BTCUSD
Bitcoin
EU
RNO
Renault
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés